Patents by Inventor Martin A. Ortega

Martin A. Ortega has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100160340
    Abstract: The present invention provides a compound of formula (I): or a pharmaceutically acceptable salt thereof which is useful in the treatment of cell proliferative diseases.
    Type: Application
    Filed: December 15, 2009
    Publication date: June 24, 2010
    Inventors: David A. COATES, Lawrence Mark GELBERT, John M. KNOBELOCH, Alfonso DE DIOS MAGANA, Ana DE PRADO GONZALEZ, Miriam FILADELFA DEL PRADO CATALINA, Maria Cristina GARCIA PAREDES, Eva Maria MARTIN DE LA NAVA, Maria Dolores MARTIN ORTEGA FINGER, Jose Antonio MARTINEZ PEREZ, Ana Isabel MATEO HERRANZ, Carlos PEREZ MARTINEZ, Concepcion SANCHEZ MARTINEZ
  • Publication number: 20090158783
    Abstract: A balance ring for washing machine devices as may be used in vertical and horizontal axis washing machines is provided. One structural arrangement of the ring comprises alternatively disposed positive and negative curved blades, as well as curved and straight blades, that in combination with the different heights of the blades, reduce the time and the amplitude of the vibrations of the transition state, thus enabling the washing basket to spin at higher velocities, and reducing the centrifugal cycle while increasing the centrifugal force applied to the objects being washed. Such an structural arrangement provides a superior drying of the clothes and further results in energy savings.
    Type: Application
    Filed: December 19, 2008
    Publication date: June 25, 2009
    Inventors: Leonardo Urbiola Soto, Alfonso Thompson Salinas, Martin Ortega Brena
  • Patent number: 7321056
    Abstract: The present invention is directed to a novel compound, its composition and use of a compound having a structural formula (I), or a pharmaceutically acceptable salt, solvate, hydrate or stereoisomers thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases
    Type: Grant
    Filed: December 8, 2004
    Date of Patent: January 22, 2008
    Assignee: Eli Lilly and Company
    Inventors: Rafael Ferritto Crespo, Maria Dolores Martin-Ortega Finger
  • Patent number: 7220880
    Abstract: The present invention is directed to compounds, compositions, and use of compounds the structural Formula (I)
    Type: Grant
    Filed: June 11, 2003
    Date of Patent: May 22, 2007
    Assignee: Eli Lilly and Company
    Inventors: Rafael Ferritto Crespo, Jose Alfredo Martin, Maria Dolores Martin-Ortega Finger, Isabel Rojo Garcia, Quanrong Shen, Alan M Warshawsky, Yanping Xu
  • Publication number: 20070066683
    Abstract: The present invention is directed to a novel compound, its composition and use of a compound having a structural formula (I), or a pharmaceutically acceptable salt, solvate, hydrate or stereoisomers thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.
    Type: Application
    Filed: December 8, 2004
    Publication date: March 22, 2007
    Inventors: Rafael Ferritto Crespo, Maria Martin-Ortega Finger
  • Patent number: 7192982
    Abstract: Disclosed is a compound represented by Structural Formula (I): Ar is a substituted or unsubstituted aromatic group. Q is a covalent bond, —CH2— or —CH2CH2—; W is a substituted or unsubstituted alkylene or a substituted or unsubstituted heteroalkylene linking group from two to ten atoms in length, preferably from two to seven atoms in length.
    Type: Grant
    Filed: May 30, 2002
    Date of Patent: March 20, 2007
    Assignees: Ligand Pharmaceuticals, Inc., Eli Lilly and Company
    Inventors: Dawn Alisa Brooks, Alan M. Warshawsky, Chahrzad Montrose-Rafezadeh, Anne-Reifel Miller, Lourdes Prieto, Isabel Rojo, Jose Alfredo Martin, Maria Rosario Gonzales Garcia, Alicia Torrado, Rafael Ferritto Crespo, Carlos Lamas-Peteira, Robert J. Ardecky, Maria Martin-Ortega Finger
  • Publication number: 20050020684
    Abstract: Disclosed is a compound represented by Structural Formula (I): Ar is a substituted or unsubstituted aromatic group. Q is a covalent bond, —CH2— or —CH2CH2—; W is a substituted or unsubstituted alkylene or a substituted or unsubstituted heteroalkylene linking group from two to ten atoms in length, preferably from two to seven atoms in length.
    Type: Application
    Filed: May 30, 2002
    Publication date: January 27, 2005
    Inventors: Dawn Brooks, Alan Warshawsky, Chahrzad Montrose-Rafezadeh, Anne-Reifel Miller, Lourdes Prieto, Isabel Rojo, Jose Alfredo Martin, Maria Rosario Gonzales Garcia, Alicia Torrado, Rafael Crespo, Carlos Lamas-Peteira, Robert Ardecky, Maria Martin-Ortega Finger